Yu Jia

469 total citations
14 papers, 373 citations indexed

About

Yu Jia is a scholar working on Molecular Biology, Hematology and Spectroscopy. According to data from OpenAlex, Yu Jia has authored 14 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Spectroscopy. Recurrent topics in Yu Jia's work include Acute Myeloid Leukemia Research (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Yu Jia is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Yu Jia collaborates with scholars based in United States, China and Türkiye. Yu Jia's co-authors include Yue Wei, Hui Yang, Yumin Hu, David Cogdell, Guillermo Garcia‐Manero, Ilya Shmulevich, Ming Zhang, Weigang Tong, Jean Viallet and Guillermo Garcia-Manero and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Yu Jia

12 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Jia United States 8 259 76 69 48 44 14 373
Matthieu Broussas France 10 134 0.5× 49 0.6× 83 1.2× 15 0.3× 94 2.1× 20 341
Carolina Castilla Spain 12 263 1.0× 45 0.6× 67 1.0× 29 0.6× 105 2.4× 17 416
Colton M. Miller United States 8 276 1.1× 20 0.3× 45 0.7× 36 0.8× 17 0.4× 11 370
Chu Myong Seong South Korea 12 360 1.4× 119 1.6× 36 0.5× 26 0.5× 133 3.0× 30 511
Chinmay Munje United Kingdom 7 186 0.7× 146 1.9× 70 1.0× 14 0.3× 39 0.9× 11 323
Frank Schwoebel Netherlands 11 210 0.8× 223 2.9× 76 1.1× 18 0.4× 63 1.4× 16 528
Axel-Rainer Hanauske Germany 8 266 1.0× 27 0.4× 22 0.3× 65 1.4× 209 4.8× 17 494
Iryna Kolosenko Sweden 11 237 0.9× 43 0.6× 68 1.0× 15 0.3× 116 2.6× 19 383
Yi Su China 12 374 1.4× 28 0.4× 46 0.7× 13 0.3× 72 1.6× 20 514
Zhi Qi China 11 331 1.3× 26 0.3× 45 0.7× 30 0.6× 85 1.9× 32 502

Countries citing papers authored by Yu Jia

Since Specialization
Citations

This map shows the geographic impact of Yu Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Jia more than expected).

Fields of papers citing papers by Yu Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Jia. The network helps show where Yu Jia may publish in the future.

Co-authorship network of co-authors of Yu Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Jia. A scholar is included among the top collaborators of Yu Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Jia. Yu Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Deng, Wenhong, Rongze Sun, Wenyi Guo, et al.. (2016). Severity of pancreatitis-associated intestinal mucosal barrier injury is reduced following treatment with the NADPH oxidase inhibitor apocynin. Molecular Medicine Reports. 14(4). 3525–3534. 29 indexed citations
4.
Dimicoli, Sophie, Yue Wei, Carlos E. Bueso‐Ramos, et al.. (2013). Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes. PLoS ONE. 8(8). e71120–e71120. 60 indexed citations
5.
Wei, Yue, Rui Chen, Sophie Dimicoli, et al.. (2012). Deregulation of TLR2-JMJD3 Innate Immunity Signaling, Including a Rare TLR2 SNP As a Potential Somatic Mutation, in Myelodysplastic Syndromes (MDS). Blood. 120(21). 1700–1700. 1 indexed citations
6.
Dimicoli, Sophie, Yue Wei, Rui Chen, et al.. (2012). Toll-Like Receptor (TLR) Signaling Adaptor Protein MYD88 in Myelodysplastic Syndromes (MDS). Blood. 120(21). 556–556. 1 indexed citations
8.
Wei, Yue, Tapan M. Kadia, Weigang Tong, et al.. (2010). The Combination of a Histone Deacetylase Inhibitor with the Bcl-2 Homology Domain-3 Mimetic GX15-070 Has Synergistic Antileukemia Activity by Activating Both Apoptosis and Autophagy. Clinical Cancer Research. 16(15). 3923–3932. 58 indexed citations
9.
Hu, Yumin, Weiqin Lu, Gang Chen, et al.. (2010). Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate. Blood. 116(15). 2732–2741. 86 indexed citations
10.
11.
Wei, Yue, George A. Călin, Yu Jia, et al.. (2010). Analysis of Regulatory miRNAs of Histone Demethylase JMJD3 In MDS CD34+ Hematoprogenitor Cells. Blood. 116(21). 609–609. 1 indexed citations
12.
Jiang, Rongcai, Ilya Shmulevich, David Cogdell, et al.. (2006). Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. PROTEOMICS. 6(10). 2964–2971. 55 indexed citations
13.
Akkіprіk, Mustafa, Daniel Nicorici, David Cogdell, et al.. (2006). Dissection of Signaling Pathways in Fourteen Breast Cancer Cell Lines Using Reverse-Phase Protein Lysate Microarray. Technology in Cancer Research & Treatment. 5(6). 543–551. 19 indexed citations
14.
Shmulevich, Ilya, David Cogdell, Woonyoung Choi, et al.. (2005). Robust estimation of protein expression ratios with lysate microarray technology. Computer applications in the biosciences. 21(9). 1935–1942. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026